Market Access Monitor
Service of monitoring key reimbursement and HTA developments for medical devices, in-vitro diagnostic tests, and digital technologies in Europe and globally
Recent news and posts
Regular update of the Norwegian Laboratory Code System released
On November 23, 2024, the Norwegian Directorate of Health released an updated version of the Norwegian Laboratory Code (NLK) system (Norsk laboratoriekodeverk 7280.74) and associated tariffs (Laboratoriekodeverk som gir rett til refusjon) for state and private laboratories to be implemented no later than January 1, 2025. NLK system is used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) for laboratory tests performed in outpatient settings.
Thirty-two new codes were added, 29 codes were removed, and 222 codes were changed.
Some examples of newly introduced codes are provided below:
- NPU62989 U-hCG (urine);
- NPU62958 Sp-CEA (spinal fluid);
- NPU18741 Secr-Bordetella pertussis culture (secretions);
- NPU58464 Us-Rubella virus RNA (unspecified sample);
- NPU60925 P-Herpes simplex 2 virus DNA (plasma);
- NPU62914 Us-Candida DNA (unspecified sample);
- NPU62995 Us-Corynebacterium diphtheria culture (unspecified sample);
- NPU63016 P-Cryptococcus antigen (plasma);
- NPU62908 F-Escherichia coli (EHEC) Shiga toxin 1 DNA (feces);
- NPU63011 P-Fenfluramine (plasma).
See the full details in Norwegian here (codes) and here (tariffs).
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.